🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to compare the pharmacokinetic and pharmacod...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00653822
Comparison of two dosing regimens of Alefacept in subjects weighing between...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00674063
Treatments Being Tested
An extension study to evaluate safety and tolerability of up to 3 additiona...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT00692172
Treatments Being Tested
To establish the safety of alefacept when administered to adolescent subjec...
Status
Completed
Location
Pediatric and Adolescent Dermatology
Start Date
2009-04
Trial ID
NCT00808223
Treatments Being Tested
The purpose of this study is to assess Alefacept in combination with alemtu...
Status
Terminated
Location
Northwestern Memorial Hospital
Start Date
2010-07
Trial ID
NCT01163799
Treatments Being Tested
To assess the efficacy and safety of Alefacept compared to placebo for the ...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00673556
The study is a prospective, multi-centre, observational study designed to a...
Status
Terminated
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00795353
Treatments Being Tested
Randomized, double-blind, 24-week study of patients with psoriatic arthriti...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00659412
Treatments Being Tested
Assess the efficacy and safety of alefacept with nbUVB compared to alefacep...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00658606
Treatments Being Tested
To evaluate the safety of treating subjects with up to 12 additional doses ...
Status
Completed
Location
Monheit Dermatology Associates
Start Date
2004-07
Trial ID
NCT00168753
Treatments Being Tested